In vitro characterisation of alloreactivity induced by isolated HLA antigens of interest is an important tool for the dissection of permissive and non-permissive HLA mismatches, one of the challenges of modern transplantation biology. The use of autologous antigen presenting cells (APCs) transfected with the HLA allele of interest is hampered by the scarce transfectability of professional APCs. In this study, we have circumvented this problem by use of autologous, PHA-activated T cell blasts as APCs. These cells are readily transfected with HLA alleles of interest by retroviral vector mediated gene transfer and subsequent purification of transduced cells by immunobead selection for the cell surface marker NGFr. These T cell blasts were capable of efficient and specific stimulation of alloresponses in mixed lymphocyte cultures The system is currently being used to study in vitro alloreactivity induced by permissive or non-permissive HLA DP 1 a lleles. Another application will be induction of single alloantigen specific regulatory T cells that could be useful for tolerance induction in mismatched haematological stem cell transplantation.
In vitro characterisation of alloreactivity induced by isolated HLA antigens of interest is an important tool for the dissection of permissive and non-permissive HLA mismatches, one of the challenges of modern transplantation biology. The use of autologous antigen presenting cells (APCs) transfected with the HLA allele of interest is hampered by the scarce transfectability of professional APCs. In this study, we have circumvented this problem by use of autologous, PHA-activated T cell blasts as APCs. These cells are readily transfected with HLA alleles of interest by retroviral vector mediated gene transfer and subsequent purification of transduced cells by immunobead selection for the cell surface marker NGFr. These T cell blasts were capable of efficient and specific stimulation of alloresponses in mixed lymphocyte cultures The system is currently being used to study in vitro alloreactivity induced by permissive or non-permissive HLA DP 1 a lleles. Another application will be induction of single alloantigen specific regulatory T cells that could be useful for tolerance induction in mismatched haematological stem cell transplantation.
A NOVEL METHOD TO DETECT SOLUBLE HLA-G SECRETING CELLS Vera Rebmann, Annika Busemann, Monika Lindemann, and Hans Grosse-Wilde Institute of Immunology, University Hospital of Essen, Germany Soluble HLA-G (sHLA-G) molecules exist in the peripheral blood of healthy females and males, in cord blood and other body fluids. To identify sHLA-G secreting cells a rabbit antiserum (Ra-HLA-G/I-4) was generated against a peptide specific for Intron-4 being expressed by sHLA-G isoforms. By the use of Ra-HLA-G/I-4 for capturing and an anti-human 2-microglobulin mAb for detection a sHLA-G specific ELISpot assay was developed. To verify this sHLA-G ELISpot format the anti-HLA-G specific mAb MEM/G9 was used in parallel as capture reagent. The ELISpots were analysed in view of the spot numbers and the average of optical densities. For the sHLA-G positive tumor cell lines JEG3 and JUSO 12.5000 cells per well and a culture time of 24 h were found to be optimal for identification of distinct spots. In the presence of INF-α,β,γ and IL-10 the number of spots increase in a concentration dependent manner, reaching a maximum at an IFN-α,β,γ concentration of 500 U/ml and an IL-10 concentration of 50 ng/ml. Interestingly, the average of optical densities did not vary substantially in these experiments. So these results indicate that the number of sHLA-G secreting cells increased whereas the amount of secreted molecules per cell seemed to be stable. In addition monocytes, CD8 and CD4 T cells from 5 healthy controls were tested for the ability to secret sHLA-G. By a constant cell number (50.000/well) the number of specific spots were significantly (p < 0.001) increased in monocytes (mean: 79.8 ± 13.2 SEM) compared to CD8 (17.1 ± 7.1 SEM) and CD4 T cells (15.3 ± 9.4 SEM) suggesting that monocytes are the main producers of sHLA-G in the peripheral blood of healthy individuals. We have developed a uniform approach for DRB1, DPB1 and DQB1 SBT.
Design requirements were that the assays be easy to use and amenable to high and low throughput with a minimal number of ambiguities. The general strategy for each of these assays is a single amplification followed by 3 sequencing reactions.
Our most recent Class II assay is a DQB1 single tube PCR that amplifies both exons 2 and 3. The exon 2 PCR amplifies all DQB1 alleles and is sequenced in both the forward and reverse directions. The exon 3 PCR amplifies only DQB1*02 and *03 alleles and is sequenced in the forward direction only. The allele specific exon 3 amplification is included to eliminate the majority of DQB1 ambiguities which are DQB1*0201 or *0202 and DQB1*0301 or *0309. While the exon 3 results will be uninformative in some cases, we have found that it is far less time consuming to run the exon 3 sequence initially rather than retrospectively. To take advantage of this streamlined approach, reactions were set up using repeat and multi-channel pipettors and sequence data was generated on an ABI 3100 (16 capillary) DNA sequencer. This DQB1 method has been validated using 50 DNAs from the UCLA DNA exchange, representing all common DQB1 alleles. Examples of unique alleles that were included in the panel are DQB1* 0611 and *0309, the DQB1*0309 containing a 3 base pair deletion in exon 3.
The successful validation of this DQB1 assay has proven that DRB1, DPB1 and DQB1 SBT can be accomplished using a single uniform approach.
THE STRUCTURE OF THE 5' PART OF INTRON 2 GIVES NEW INSIGHT IN THE EVOLUTION OF HLA-DQB1
Holger-A. Elsner, Sabine Kriens, Rainer Blasczyk. Department of Transfusion Medicine, Hannover Medical School, Hannover, Germany
The structure of the non-coding regions may deliver invaluable information about the evolution of HLA genes. In this study we have sequenced 500 bp of the 5' part of the large intron 2 of HLA-DQB1. The study was based on 30 samples of varied ethnic origin, representing 16 DQB1 alleles. Phylogenetic relationships and evolutionary parameters were computed of intron 2 and exon 2. For most alleles, the dendrograms showed clear lineage specificity; however DQB1*0301 and DQB1*0601 clustered distinct from the other variants of the respective allelic groups. Since a similar relationship was previously observed in intron 1, the two alleles thus might represent independent lineages. Accordingly, one might speculate that these variants have obtained their "DQ3" or "D Q6" character through exonic recombination with members of the DQ3 or DQ6 "core families". Another exception from lineage specificity is given by the other DQB1*03 alleles, which cluster together with the alleles of the DQB1*04 group. This finding is likely to indicate previous recombination in exon 2 leading to subsequent homogenization of intron 2 through genetic drift. The study of nucleotide substitution rates yielded no further evidence for enhanced exonic recombination since, unlike in the case of overdominant selection, the synonymous nucleotide substitution rate s in exon 2 (0.09729) did not exceed π in intron 2 (0.10784). In conclusion, the structure of intron 2 supports the idea that DQB1 is subjected to moderate evolutionary pressure, which might reflect the evolutionary strategy to generate DQ antigen diversity both by interallelic recombination and by haplotype diversity in the linkage with DQA1.
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Poster Group I -Genomic Analysis of MHC and Related Genes Over the past three years, one of the main goals of our laboratory has been to develop sequencing-based typing assays for HLA-A, -B and -C genes. A critical component to this development has been reliable intron information for the design of PCR and sequencing primers. Due to the inadequacies of publicly available intron databases, we have generated complete noncoding region sequence of the major HLA-B and -C alleles. Beyond the utility of primer design, the intron database has yielded interesting and useful information. This includes new allele variants and their relationships to certain HLA haplotypes and insights into the evolution of HLA-B and -C allele groups. Recently, there have been a number of new findings that include a new allele variant and additional allele sequences added to this database. Here we describe these new findings and additions and provide a summary of the information contained within this intron sequence database.
MCP-1 PROMOTOR POLYMORPHISM IN SPANISH PATIENTS WITH RHEUMATOID ARTHRITIS
Maria Francisca González-Escribano, Belén Torres, Francisco Aguilar, Rosa Rodríguez, Alicia García, Ángel Valenzuela, and Antonio Núñez-Roldán. Servicio de Inmunología. HU Virgen del Rocío. Servicio Andaluz de Salud. Sevilla. Spain.
Monocyte chemoattractant protein-1 (MCP-1) is a -chemokine likely to be responsible for mononuclear cell accumulation in synovium. Thus, genetic polymorphisms in the regulatory regions of the MCP-1 gene could be involved in the susceptibility or progression of rheumatoid arthritis (RA). A biallelic G/A polymorphism at position -2518 of the MCP-1 gene has been described and this polymorphism seems to influence the transcriptional activity. With the aim to investigate the possible role of this polymorphism in the susceptibility and clinical outcome of RA, 141 RA Spanish patients and 194 controls, previously typed for HLA-DRB1*, were genotyped using PCR-RFLP. No association between -2518 (A/G) MCP-1 polymorphism and susceptibility to RA was found. Nevertheless, when patients and controls were stratified according to their HLA shared epitope (SE) status, a significant increase in the frequency of genotype GG was found among SE negative (SE-) patients with respect to both SE positive (SE+) patients and SE-controls (16% vs. 4% in SE+ patients; pFisher=0.04, OR=4.4, 95%CI: 1.03-21.48; and 4% in SE-controls; pFisher =0.02, OR=4.13, 95%CI 1.10-15.72). No significant differences were found between the different groups of patients classified according to their clinical course. In conclusion, MCP-1 polymorphism is slightly associated with the susceptibility to RA in patients lacking the HLA SE. No influence of this polymorphism in the outcome was observed.
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SEQUENCING When a search for an unrelated donor of HSCT was performed for a patient suffering from leukaemia, no donor was found neither in the extended family nor in the BMDW registries. A family study revealed two rare haplotypes (HLA-A*0101, Cw*0202, B*1503, DRB1*1110 DRB3*0202 DQB1*0602/HLA-A*6801, Cw*0401, B*3520, DRB1*0407, DRB4*0101, DQB1*0302), their origins can be traced to the Mapuche population. Mapuche ("people of the earth") designates an ethnic group of Indians in South America , characterised by groups of consanguineous relatives who lived gathered in communities. The search for a compatible donor is now being pursued in the Mapuche population. HLA-DNA typing is performed by both low and high resolution techniques, including SSO typing by reverse dot blot (Reli) and nucleotide sequencing. In the fourteen members so far analysed, HLA alleles rarely found in Caucasoids are evident. A new HLA-C alleles was also observed in two individuals. This allele resembles the HLA-Cw*1602 alleles but has two substitutions in exon 3, one synonymous and one non-synonymous leading to an exchange of Alanin to Serin at position 136 of the HLA-C molecule. Therefore, Mapuches have a peculiar distribution of HLA alleles, making the finding of unrelated donors for patients in registries world-wide difficult, but contributing to the wealth of HLA-alleles.
A NEW ALLELE WITHIN THE TRANSMEMBRANE REGION OF THE HUMAN MICA GENE WITH SEVEN GCT REPEATS Blanca Rueda 1 , María Pascual 1, Elena González1, Javier Martín 1. 1 Instituto de Parasitología y Biomedicina "López-Neyra", CSIC, Granada, Spain.
Major histocompatibility complex class I chain-related genes (MIC) belongs to a multicopy gene family located within the HLA class I region in the chromosome 6. They encode for proteins whose organization, expression and products differ considerably from classical HLA class I gene products: they do not bind neither 2 microglobulin nor peptide ligands, are mainly expressed by epithelial cells after stress conditions, and binds with the NKG2D receptor. One member of this family its the MICA gene wich lies 40 Kb centromeric of HLA-B and is structured in six exons that encode respectively for leader peptide, the extracellular domains a transmembrane region (TM) and a cytoplasmatic tail. The MICA gene is characterised by its high degree of polymorphism with over 50 MICA alleles described. Moreover MICA exon 5 presents a microsatellite polymorphism consisting in a variable number of GCT repeats that encodes for 4, 5, 6, 9, or 10 alanine residues respectively and a variant (MICA A5.1) that includes a nucleotide insertion (GCT→GGCT). Here, we report a novel microsatellite repetition consisting in seven GCT repeats found in a family based study of MICA polymorphism in celiac disease. This new allele, following the previously described nomenclature, was named MICA "A7" and it has been shown to be identical to the MICA*002 allele with the exception of the number of GCT repeats, codifying for 7 alanines in the MICA gene TM region. Several studies have demonstrated a high level of recombination between HLA DQB1and DPB1. Other studies have suggested that positive and negative linkage associations between HLA alleles including DPB1 confer susceptibility to certain autoimmune diseases.
The ancestral haplotype 8.1 (HLA A1,B8, DR3) is the most commonly found haplotype in caucasian populations with a frequency of 0.09 in the U.K.. We identified 16 informative families among our Bone Marrow Transplant patients with this ancestral 8.1 haplotype. Within the 16 families we looked for allelic variation at the following loci HLA A, B, Cw, DRB1, DQB1 and DPB1 for the familial 8.1 haplotypes.
We extended our analysis to look at the allelic frequencies for DPB1* within the familial 8.1 ancestral haplotypes and contrast their frequencies with the DPB1* frequencies found within registered bone marrow donors for the West of England (British Bone Marrow Donor Registry) and the published DPB1* frequencies for Welsh blood donors. Our findings show no allelic variation within the 8.1 haplotype for the HLA A, B ,Cw, DRB1* , DQB1* alleles. The DPB1* alleles found on the same chromosome as the 8.1 haplotype within these families approaches the same frequencies found among the bone marrow donors from the West of England typed for DPB1* and published frequencies for Welsh blood donors.
ANALYSIS OF THE POLYMORPHISM IN THE HLA-DQB1 PROMOTER REGION IN SPANISH POPULATION.
Manuel Muro, Luis Marín, Alberto Torío, Rosa Moya-Quiles, Olga Montes, María Montes, Natalia Guerra, Jose Alemany, Ana García-Alonso, Rocío Álvarez. (Immunology Service. Hospital Virgen Arrixaca, Murcia, Spain).
Allelic diversity in the promoter and associated regulatory elements of the HLA class II genes has also been reported as an additional source of variation. Since mutations in the X1, X2 and W boxes without variability in the Y box have been reported and there was not any study of the DQB1 promoter region (QBP) allele frequencies in spanish population, the present work was focused to investigate the QBP alleles and QBP-DQB1 haplotypes distribution.
Unrelated Caucasoid donors from Murcia Region in the Southeast of Spain were included in this study (n=108) which have previously been oligotyped for MHC-class II alleles. QBP DNA typing was carried out by PCR-SSO and PCR-SSP methods in accordance with protocols and reagents from the 12th IHW. The most prevalent allele was QBP2.1 followed by QBP5.11, 3.1, 6.2, 6.3, 3.21, 5.12 and 6.11. The frequencies seen for QBP3.22, 3.3 and 4.1 alleles were of less than 2%. The allele frequencies of the promoter corresponded by and large to the frequencies observed for the linked DQB1 alleles, as tight linkage was seen between promoter region and the second exon of the DQB1 gene, except for DQB1*0302, *0501 and *0604 alleles. DQB1*0302 allele was found in linkage with QBP3.21, 3.22 and 3.3 variants. DQB1*0501 allele was found in linkage with QBP5.11 and 5.12 alleles and DQB1*0604 allele with QBP6.2 and 6.3 variants. Furthermore, the promoter alleles QBP3.3, 4.1, 5.11, 6.2 and 6.3 were linked to at least two different DQB1 alleles: QBP3.3 was seen in linkage with DQB1*0302 and *0303. QBP4.1 was linked to DQB1*0401 and *0402, and QBP5.11 was seen with DQB1*0501, *0502 and *0503. QBP6.2 was linked to DQB1*0602 and *0604, and QBP6.3 was observed with DQB1*0603 and *0604. Therefore, as occurs in other studied populations, QBP alleles exhibit strong linkage disequilibrium with the HLA-DQB1 locus. HLA genes encode the most polymorphic human proteins known to date: HLA-DRB1 locus has more than 300 different alleles.
In this report we describe a new HLA-DRB1 allele detected during routine sequence based typing (SBT). This allele has been found in an Italian patient suffering from multiple mieloma, his mother and one of his brothers.
The exon 2 was sequenced completely in both forward and reverse orientations showing an inconclusive DRB1*11 typing. To further characterise this potentially new allele direct sequencing of the exon 2 was performed using a group-specific amplification, following the WHO Nomenclature Committee for Factors of the HLA System recommendations. Amplification and sequencing reactions were carried out according to the 13th International Histocompatibility Workshop protocol. This new allele differs from HLA-DRB1*110101 only for a single base substitution at codon 38 where Alanine (GCG) replaces Valine (GTG).
Residue 38 is likely to contribute to the peptide binding site of HLA-DR11 and thus this amino acid change is to be well considered. Recent amino acid classification studies indicate that alanine and valine have the same physico-chemical properties but literature don't safely assign A and V to the same cluster so that we do not currently know if the exchange at codon 38 has or not a high impact on the peptide binding site function and therefore if it may be or not significant in the clinical outcome of bone marrow transplantation. Twenty-four out of 125 HLA-C allelic variant described to date, display critical polymorphisms for allele assignment in exons 1,4,5,7 and in intron 2. Sequencing beyond exon 2 and 3 is then essential for ambiguity resolution of these alleles showing identical nucleotide sequences over these exons. Although these ambiguities are restricted to subtypes, they include discrimination of alleles characterized by different amino acid sequences and of expressed Cw*040101 allele versus Cw*0409N null allele. Recognition of such allelic variants may be of great importance for HLA matching in allogeneic transplantation and in the characterization of cellular interactions involved in immune response. High resolution sequence based typing (SBT) we provide allows the analysis of polymorphisms distributed troughout HLA-C region. Briefly SBT strategy involves one PCR amplification encompassing 5' untraslated region to intron 3 and six direct sequencing reactions of PCR product covering exons 1, 2, 3 and intron 2 and a second PCR amplification (1434 bp) encompassing intron 3 to 3' untraslated region and six direct sequencing reactions covering exons 4,5,6,7,8.
From our data a novel HLA-Cw*07 allele, Cw*0718 (the name Cw*0718 has been officially assigned by the WHO Nomenclature Committee in December 2002), was detected in one sample. Cw*0718 differs from Cw*070101 by a nonconservative aminoacid substitution HLA-Cw*16 is a relatively common HLA-C specificity among Caucasoids, which comprises the Cw*1601, Cw*1602 and Cw* 16041 allele variants. Cw*1601 is the most frequent of them among the Spanish population and Cw*1602 was described as a new susceptibility marker of Behçet's disease in Southern Spain.
We report herein the identification by SBT of a new HLA-Cw*16 allele in a Spanish Caucasoid organ donor. The novel allele differs from Cw*1601 by two nucleotide changes at positions 361 (T to A) and 368 (A to C) in exon 3, thus leading to two amino acid changes from Trp (TGG) to Arg (AGG) and from Tyr (TAT) to Ser (TCT) at codons 97 and 99 in the 2 domain, respectively.
The amino acid positions 97 and 99 locate at the floor of the peptidebinding groove and are constitutive residues of pockets for accommodating the associated peptides, making them likely relevant to antigen presentation. The two single nucleotide changes originating the two amino acid substitutions in the new Cw*16 specificity have not been found in any other HLA-A, -B and C sequences with the exception of that of Cw*0105, Cw*0702 and Cw*0703. This suggests that the new Cw*16 variant here reported could have arisen from an intra-locus gene conversion event between any of these three HLA-C alleles and Cw*1601. HLA-B typing using PCR-SSP revealed a reaction pattern that did not fit to any known HLA specificity. SSP-primers originated from the Collaborative Transplant Study. Serological typing showed positive reactions only with some of the B56 specific antisera. Family typing showed an association of B*5611 with A*11, Cw*01, DRB1*0403, DQB1*0305 and DQA1*03.
DESCRIPTION OF
Sequencing of exons 2 and 3 of the HLA-B locus after allelic separation with specific primers (Protrans S4 and own primers) revealed the sequence of a new allele, B*5611. Exon 2 of this allele is similar to most B*55 and 56 alleles whereas exon 3 sequence is similar to most B35 alleles. Sequencing of exons 1 and 4 with own primers showed patterns conclusive with most B*55/56 alleles. Therefore the new allele might be the result of a double crossing over between a B*55/56 and a B*35. In 1998 we found a new HLA-A19 allele in a potential kidney recipient from Thuringia (southeast of Germany).
RENAMING OF HLA-
Serological class I and PCR-based class II typing revealed the HLA pattern A11,19; B27,52; Cw2,-; DRB1*0101,1502; DRB5*0102; DQB1*0501,0601; DPB1*0401,0901. Repeated serological HLA-A typing with several different sets of sera revealed A11,-; A11,19 and A11,31.
In order to determine the HLA-A19 split antigen, HLA-A typing was done by PCR-SSP. As with serology, we found inconclusive amplification patterns even with different PCR-SSP sets. Therefore we sequenced the exons 1-4, the introns 1-3 and the 5'flanking region of this allele after haplotype specific PCR amplification. This sequence analysis showed a new HLA-A allele which is identical to A*3101 with the exception of the 3' half of exon 2 which is identical to the common A9 alleles.
The phylogenetic tree constructed with the nearest-neighbour algorithm based on exon 1-4 and/or non-coding sequences clearly indicated that A*2416 belongs to the A19 lineage. Probably this allele was created by the insertion of a segment of HLA-A*2402 (donor) from codons 57 to 83 into the background of an HLA-A*31012 allele (acceptor).
In Although Turks represent approximately 2-3% of the German population, only very few of them are registered as potential stem cell donors (SCD). This also holds for Turkish stem cell donor registries. Additionally German and Turkish HLA haplotypes differ frequently. Consequently it is often difficult to find a suitable donor for Turkish patients in Germany, and in some cases stem cells are even imported from Taiwan.
On the occasion of regular HLA-typing we have detected a new HLA-DR13 allele in a Turkish SCD. In two different SSO systems we found unexpected band patterns. To control and verify these results, we applied an ABI HLA SBT kit. DNA sequencing with the according kit showed an 'HLA-DRB1*1324-like allele'. But only a part of the complete exon 2 sequence was distinguished. We then used the equivalent protrans S4 SBT kit, and were able to identify the whole exon 2 and parts of the adjacent introns.
After submission of the exon 2 sequence to the GeneBank/ EMBL and to the WHO Nomenclature Committee for Factors of the HLA System, the new allele was named HLA-DRB1*1354.
The new allele differs in 3 nucleotides and 3 amino acids in known variable positions from DRB1*1324. HLA-DRB1*1354 could result from a gene conversion event between DRB1*1304 as acceptor and DRB1*07 (0701-04, 0707) or DRB1*12 (1201, 1203, HLA-DRB1*01 is not one of the most polymorphic group of HLA class II genes so until now only eight alleles have been described. We describe the identification of a new allele using sequence based typing found in three members of a Caucasian Italian family. A male hematologic patient in need of a bone marrow transplant was routinely typed by pcr-SSOrev and DRB1*01 allele was identified but not correctly assigned as a result of an atypical oligonucleotide pattern.
The patient and his sister were identical and typed as: A* 24021; B*1402,*1517; DRB1*13021,*01new; DQA1*0101,*0102; DQB1* 0501, 0604. The mother was typed as follow: A*0301, 24021;B*1402,*44031; DRB1*0402,*01new; DQA1*0101,*0301; DQB1* 0501,*0302 while the father was not typed because he had died a few years previously. The haplotype of the new allele is A*24021; B*1402; DRB1*01new; DQA1*0101;DQB1*0501.
Genomic DNA was sequenced using the HLA DRB High Resolution Typing System ( Applied Biosystem, Foster City,CA). The primer pairs specific for DRB1*01 gave an amplification products which was subsequently sequenced using an ABI PRISM 310 Genetic Analyzer.
The nucleotide sequence of exon 2 of the new allele is identical to that of DRB1*01021 except in position 102 where the adenine of the consensus was replaced by a guanine. This does not give rise to an aminoacid substitution. The same DRB1 sequence was also confirmed in the patient's sister and mother. The allele has been submitted to obtain an official assign (AJ430382.1).
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HLA-DRB1*0107 -A CASE STUDY IN A FAMILY Helmut K. G. Machulla, Joannis Mytilineos, Universities of Halle and Heidelberg, Germany HLA-DRB1*0107 is reported in a single case ZAE and for a mother/child pair IOL (http://www.ebi.ac.uk/Services/imgt/hla/). It is designated as a new allele (Marsh e.a., Tiss. Ags 57, 2001, 236) . We demonstrate the inheritance of the new allele in a German fa-mily with Caucasian origin. The allele could be revealed by use of high resolution PCR-SSP techniques (Genovision, One Lambda), but not by low resolution PCR-SSP technique (Genovision, Dt. Dynal, BAG). The allele was confirmed by SBT (Protrans-Kit, house-kit of University of Hei-delberg). By serological typing (MDR-One Lambda) the DRB1* 0107 positive probands were shown to express the antigen HLA-DR1. The father had the combination of DRB1*0101,0107. These two DR1-alleles were segregating to different children. The allele HLA-DRB1*0107 was included and in herited in the haplotype A*03:Cw*04:B*35:DRB1*01:DQB1*0501.
The allele HLA-DRB1*0107 is confirmed now in a further case demonstrating its segregation in a family. These individuals could not be identified as DR1 positive individuals by the commercially available PCR-SSP low resolution technique, whereas a serologic prove of HLA-DR1 was possible.
